References

Continued benefit to rectal separation for prostate radiation therapy: final results of a phase III trial

10.1016/j.ijrobp.2016.12.024 · 2017 · External reference

Comparison of intensity-modulated radiotherapy with the 5-field technique, helical tomotherapy and volumetric modulated arc therapy for localized prostate cancer

10.1093/jrr/rrac027 · 2022 · External reference

Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers

10.1016/j.ijrobp.2007.03.029 · 2007 · External reference

Intrafractional motion of the prostate during hypofractionated radiotherapy

10.1016/j.ijrobp.2008.04.051 · 2008 · External reference

Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography

10.1016/j.ijrobp.2008.02.032 · 2008 · External reference

Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum

10.1016/j.ijrobp.2010.01.042 · 2011 · External reference

Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac

10.1016/j.radonc.2020.06.044 · 2020 · External reference

Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac

10.1016/j.radonc.2021.07.014 · 2021 · External reference

Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancer

10.1093/jrr/rry089 · 2019 · External reference

Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer

10.1093/jrr/rrt124 · 2014 · External reference

Dose-volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays

10.1093/jrr/rru111 · 2015 · External reference

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

10.1038/bmt.2012.244 · 2013 · External reference

Magnetic resonance image-guided adaptive radiotherapy enables safe CTV-to-PTV margin reduction in prostate cancer: a cine MRI motion study

10.3389/fonc.2024.1379596 · 2024 · External reference

Quantifying intrafraction motion and the impact of gating for magnetic resonance imaging-guided stereotactic radiation therapy for prostate cancer: analysis of the magnetic resonance imaging arm from the MIRAGE phase 3 randomized trial

10.1016/j.ijrobp.2023.12.035 · 2024 · External reference

Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 tesla MR-Linac: a practical method to mitigate intrafraction motion

10.1016/j.radonc.2022.09.004 · 2022 · External reference

Factors affecting prostate displacement during volumetric modulated arc therapy in prone position after high-dose-rate brachytherapy for prostate cancer. Adv

10.1016/j.adro.2023.101277 · 2023 · External reference

Planning target volume margin assessment for online adaptive MR-guided dose-escalation in rectal cancer on a 1.5 T MR-Linac

10.1016/j.radonc.2021.07.011 · 2021 · External reference

Understanding the benefit of magnetic resonance-guided adaptive radiotherapy in rectal cancer patients: a single-Centre study

10.1016/j.clon.2022.10.008 · 2023 · External reference

Online adaptive MRI-guided radiotherapy for primary tumor and lymph node boosting in rectal cancer

10.3390/cancers15041009 · 2023 · External reference

The importance of mesorectum motion in determining PTV margins in rectal cancer patients treated with neoadjuvant radiotherapy

10.1093/jrr/rrz092 · 2020 · External reference

Image-guided radiotherapy for rectal cancer: a systematic review

10.1016/j.clon.2011.07.012 · 2012 · External reference

Comparative analysis of kVCT- and MVCT-guided helical tomotherapy for total body irradiation: evaluation of process times and residual setup errors

10.1093/jrr/rraf062 · 2025 · External reference

A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization

10.1016/j.urology.2005.10.008 · 2006 · External reference

External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?

10.1016/j.ijrobp.2009.02.026 · 2010 · External reference

Preliminary analysis of risk factors for late rectal toxicity after helical tomotherapy for prostate cancer

10.1093/jrr/rrt025 · 2013 · External reference

A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer

10.1007/s10147-024-02517-z · 2024 · External reference

Favorable 10-year outcomes of image-guided intensity-modulated radiotherapy combined with long-term androgen deprivation for Japanese patients with nonmetastatic prostate cancer

10.1111/ajco.13097 · 2019 · External reference

Long-term outcomes of proton therapy for prostate cancer in Japan: a multi-institutional survey of the Japanese Radiation Oncology Study Group

10.1002/cam4.1350 · 2018 · External reference

Toxicity and patient-reported outcomes after moderately hypofractionated radiotherapy (60 Gy in 20 fractions) for prostate cancer: prospective observational study

10.1093/jrr/rraf059 · 2025 · External reference

Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial

10.1093/jrr/rrae026 · 2024 · External reference

Impact of neoadjuvant androgen deprivation therapy on toxicity in intensity-modulated radiation therapy for prostate cancer

10.1093/jrr/rrae056 · 2024 · External reference